In this study, MET was revealed as a direct target of miR-27b-3p, which is consistent with the previous finding that MET is a direct target of miR-27b-3p in DLBCL and MET expression can be restored by miR-27b-3p silencing (28, 29). The gene discussed is MET; the disease is diffuse large B-cell lymphoma.